HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Arkansas e-tracking PSE

This article was originally published in The Tan Sheet

Executive Summary

Sales of OTC products containing pseudoephedrine across Arkansas are being tracked on a real-time statewide electronic logbook, state Attorney General Dustin McDaniel says June 4. Arkansas was among the states that imposed behind-the-counter sales of PSE-containing OTC products before the federal Combat Methamphetamine Epidemic Act of 2006 required all states to implement sales restrictions as least as stringent (1"The Tan Sheet" July 3, 2006, p. 7). However, Arkansas found paper logbooks ineffective against meth makers who stock up on PSE drugs by visiting multiple retailers. Federal legislation, S. 1276, to fund electronic logs for states has stalled in the Senate, but Arkansas and other states - including Iowa, Oklahoma and Tennessee - have implemented their own tracking systems (2"The Tan Sheet" March 19, 2007, p. 11)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS137404

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel